# Ambelvist

NDC: 50419-332
Generic name: Gadoquatrane
Labeler / Manufacturer: Bayer HealthCare Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20260612

FDA application: NDA219627

## Active ingredients

- GADOQUATRANE: 257.9 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50419-332"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50419-332
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fac80f5d-8d37-4237-bb52-0faef0dd46aa